Arcturus Therapeutics Holdings Inc. (ARCT) › Cash & EquivalentsArcturus Therapeutics Holdings Inc. (ARCT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $36.71M2019: $71.35M2020: $462.89M2021: $370.49M2022: $391.88M2023: $292.00M2024: $237.03M2025: $230.91M$230.91M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$230.91M-2.6%2024$237.03M-18.8%2023$292.00M-25.5%2022$391.88M+5.8%2021$370.49M-20.0%2020$462.89M+548.7%2019$71.35M+94.4%2018$36.71M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share